Table 1.

Demographic and clinical characteristics of participants.

	N = 20
Age, years	72.3 ± 6.2 (61–83)
Disease duration, months	29.3 ± 18.2 (10–82)
Sex, men/women	13/7
FAB, score	12.2 ± 3.2 (6–17)
MMSE, score	26.0 ± 2.6 (22–30)
mRS, score	3.3 ± 0.6 (2–4)
PSPRS, score
I	7.3 ± 2.4 (3–11)
II	3.2 ± 2.4 (0–8)
III	2.7 ± 1.2 (1–5)
IV	6.7 ± 3.9 (0–12)
V	3.9 ± 1.3 (2–7)
VI	8.2 ± 2.1 (6–12)
Total	31.8 ± 10.0 (16–50)

Data were reported as mean ± standard deviation (minimum—maximum) and numbers.